Skip to main content
. 2014 Dec 10;89(5):2469–2482. doi: 10.1128/JVI.02828-14

TABLE 4.

Genes chosen for confirmation by qRT-PCR

Genea GenBank accession no. Description Fold changeb
BLB1 NM_001044694 MHC class II antigen B-F minor heavy chain 203–263*
SRFBP1 XM_424408 Serum response factor binding protein 1 24–25*
TNFRSF1B NM_204439 Tumor necrosis factor receptor superfamily, member 1B 8–9*
XRCC3 NM_001006489 X-ray repair complementing defective repair in Chinese hamster cells 3 14–20*
AICDA XM_416483 Activation-induced cytidine deaminase 8–57†
B6.3 X92865 B cell marker chB6 (Bu-1) 6–42†
BLVRA XM_418872 Biliverdin reductase A 8–42†
CARD9 XM_425329 Caspase recruitment domain family, member 9 3–16†
MYBL1 NM_205232 Myeloblastosis oncogene-like 1 7–37†
TLR2B AB046533 Toll-like receptor 2, type 2 4–5†
CCL19 XM_424980 CCL19 homeostatic chemokine 84–99‡
CCLi3 NM_204720 CCLi3 MIP family chemokine 76–100‡
CCLi4 NM_001045832.1 CCL5 MIP family chemokine (RANTES) 209–318‡
CXCLi2 NM_205498 CXCLi2 (IL-8 homologue) 50–65‡
IFNA EU334503 IFN-α 470–1,359‡
IFNB NM_001024836 IFN-β 51–85‡
IFNG NM_205149 IFN-γ 32–72‡
IL13RA2 NM_001048078 IL-13 receptor-α2 53–111‡
IL-6 NM_204628 IL-6 52–198‡
MMP9 NM_204667 Matrix metalloprotein 9 1,099–1,782‡
Mx1 NM_204609 Myxovirus resistance gene 1 60–69‡
a

Genes indicated in boldface are potential candidate resistance genes.

b

*, Inherently higher expression in the resistant line; †, higher expression in response to infection in the resistant than in the susceptible line; ‡, upregulated in response to infection in the susceptible line.

HHS Vulnerability Disclosure